• CD36 Lipid Signaling and Immune Escape in AML

  2026-09-05

  A 2024 Cell Reports Medicine study identifies a non-canonical CD36 lipid-sensing program that enables acute myeloid leukemia cells to suppress T-cell activity and resist decitabine therapy. Its mechanistic model separates CD36-driven innate immune signaling from lipid oxidation and supports lipid restriction with statins as a strategy for improving hypomethylating-agent responses.

• Acridine Orange hydrochloride Workflow Guide

  2026-09-04

  Acridine Orange hydrochloride provides membrane-permeable, dual-fluorescence nucleic acid staining for DNA and RNA differential staining, cell cycle analysis, and flow cytofluorometric workflows. It is best used in freshly prepared, locally validated cytochemical assays and should not be treated as a standalone apoptosis marker or stored as a solution for extended periods.

• Allosteric PDK4 Inhibitors for Metabolic Disease

  2026-09-04

  The 2019 Journal of Medicinal Chemistry study identified anthraquinone-derived allosteric inhibitors of pyruvate dehydrogenase kinase 4 (PDK4), with compound 8c reaching an in vitro IC50 of 84 nM. Its metabolic stability, pharmacokinetic behavior, and activity in diet-induced obesity, allergic-response, and cancer-related assays support PDK4 as a multi-disease drug-discovery target while leaving important translational questions open.

• Cyclophilin A Defines Cyclosporin Immunosuppression

  2026-09-03

  The reference study used Ppia knockout mice and immune-cell reconstitution to show that Cyclophilin A is the principal mediator of cyclosporine-driven immunosuppression. Its genetic evidence connects drug resistance to diminished calcineurin inhibition and provides a strong framework for interpreting T-cell assays, transplantation models, and related Cyclosporin A research.

• Mapping Astrocyte Heterogeneity with TSA Fluorescence

  2026-09-03

  Transcriptomic atlases reveal where astrocytes differ, but spatial assays must show how those differences appear in cells and tissue. This article outlines a mechanistic and translational strategy for using TSA fluorescence to validate region- and age-dependent astrocyte biology.

• Verapamil: From Calcium Flux to Hypoxic Inflammation

  2026-09-02

  Verapamil ((±)-Verapamil) is more than a calcium channel blocker: in urothelial hypoxia research, it can serve as a pharmacological perturbation of ROS-linked TXNIP/NLRP3 signaling. This article connects the compound’s cardiovascular and transporter biology with experimental design, formulation strategy, and translational limits.

• Dasatinib: A Phospho-Signaling Decision Guide

  2026-09-02

  Dasatinib (BMS-354825) is a powerful Src and Bcr-Abl inhibitor for dissecting kinase-dependent phenotypes. This guide connects its validated pharmacology with the SNAI1–PIK3R2/p-EphA2 findings in thymic epithelial tumors while emphasizing assay interpretation, model selection, and experimental limitations.

• Cyclophilin A Defines Cyclosporin Immunosuppression

  2026-09-01

  Colgan and colleagues used genetic deletion, ex vivo T-cell assays, in vivo allogeneic challenge, and adoptive reconstitution to test whether Cyclophilin A is required for cyclosporin-mediated immunosuppression. Their results show that CypA is the principal intracellular mediator of calcineurin inhibition and immune suppression by cyclosporin, providing a strong mechanistic basis for interpreting resistance phenotypes in experimental models.

• Metabolic Sensitization of Ferroptosis and Cuproptosis

  2026-09-01

  Zhang and colleagues developed a Cu–tannic acid/liposome nanosystem carrying STF-31 to inhibit glycolysis and compensatory NAD+ metabolism, thereby increasing tumor-cell susceptibility to ferroptosis and cuproptosis. The study links metabolic depletion with copper retention, redox failure, immunogenic cell death, and tumor immune remodeling, offering a mechanistic framework for combination nanomedicine design.

• PRMT6-Mediated Antiviral Immunity in Plants

  2026-08-31

  Zhu et al. identify protein arginine methyltransferase 6 (PRMT6) as a plant antiviral factor that disables the tomato bush stunt virus P19 silencing suppressor. The study connects PRMT6-dependent methylation at conserved P19 arginine residues with impaired dimerization and small-RNA binding, while natural PRMT6 expression alleles help explain variation in tomato resistance.

• Recent Advances in Ibuprofen and Naproxen Synthesis

  2026-08-31

  Ha and Paek’s review examines how ibuprofen and naproxen synthesis has evolved from established industrial routes toward more efficient, asymmetric, derivative-oriented, and continuous-flow strategies. Its main practical value is a framework for comparing step economy, stereochemical control, scalability, and route adaptability when preparing aryl-propionic acid NSAIDs.

• Rhodamine B for Nanomedicine Imaging Workflows

  2026-08-30

  Rhodamine B, also called Basic Violet 10, supports practical cell labeling, particle-tracking, and fluorescence-based assay workflows. This guide connects its use as a fluorescent reporter with a trypsin-responsive nanomedicine strategy for acute pancreatitis, while separating validated findings from assay-design recommendations.

• Trichostatin A for Organoid Epigenetic Studies

  2026-08-29

  Use Trichostatin A as a reversible chromatin perturbation tool to connect histone acetylation with organoid growth, differentiation, and cellular diversity. This workflow also positions TSA as a benchmark for cancer research, including breast cancer cell proliferation inhibition assays.

• Z-VDVAD-FMK in Caspase-2 Apoptosis Workflows

  2026-08-28

  Z-VDVAD-FMK provides a cell-permeable, irreversible way to interrogate caspase-2-linked apoptosis, mitochondrial signaling, and downstream caspase activity. Its value is greatest in orthogonal workflows that separate caspase-dependent rescue from caspase-independent cell death, including emerging host–virus studies.

• Cyclosporin A: Assays, Workflows, and Optimization

  2026-08-28

  Cyclosporin A provides a versatile way to connect cyclophilin-dependent signaling with calcineurin–NF-AT suppression and mitochondrial pore regulation. This practical guide shows how to design dose-response experiments, compare cyclosporin variants, and troubleshoot cell-based and mitochondrial assays.

8068 records 1/538 page Next 12345 下5页 Last page